Jazz Pharma’s medical cannabis unit seeks to block generic

19-01-2023

Liz Hockley

Jazz Pharma’s medical cannabis unit seeks to block generic

photolona / Shutterstock.com

UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy.


Jazz Pharma, generics, medical cannabis, epilepsy, patent infringement, FDA

LSIPR